
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
mRNA vaccination induces tick resistance and prevents transmission of the Lyme disease agent
Andaleeb Sajid, Jaqueline Matias, Gunjan Arora, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 620
Closed Access | Times Cited: 110
Andaleeb Sajid, Jaqueline Matias, Gunjan Arora, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 620
Closed Access | Times Cited: 110
Showing 1-25 of 110 citing articles:
The landscape of mRNA nanomedicine
Xiangang Huang, Na Kong, Xingcai Zhang, et al.
Nature Medicine (2022) Vol. 28, Iss. 11, pp. 2273-2287
Open Access | Times Cited: 312
Xiangang Huang, Na Kong, Xingcai Zhang, et al.
Nature Medicine (2022) Vol. 28, Iss. 11, pp. 2273-2287
Open Access | Times Cited: 312
Nanotechnology-based mRNA vaccines
Shuying Chen, Xiangang Huang, Yonger Xue, et al.
Nature Reviews Methods Primers (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 73
Shuying Chen, Xiangang Huang, Yonger Xue, et al.
Nature Reviews Methods Primers (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 73
A high-quality Ixodes scapularis genome advances tick science
Sandip De, Sarah B. Kingan, Chrysoula Kitsou, et al.
Nature Genetics (2023) Vol. 55, Iss. 2, pp. 301-311
Closed Access | Times Cited: 52
Sandip De, Sarah B. Kingan, Chrysoula Kitsou, et al.
Nature Genetics (2023) Vol. 55, Iss. 2, pp. 301-311
Closed Access | Times Cited: 52
Development of an mRNA-lipid nanoparticle vaccine against Lyme disease
Matthew Pine, Gunjan Arora, Thomas Hart, et al.
Molecular Therapy (2023) Vol. 31, Iss. 9, pp. 2702-2714
Open Access | Times Cited: 46
Matthew Pine, Gunjan Arora, Thomas Hart, et al.
Molecular Therapy (2023) Vol. 31, Iss. 9, pp. 2702-2714
Open Access | Times Cited: 46
PEDV-spike-protein-expressing mRNA vaccine protects piglets against PEDV challenge
Yongxiang Zhao, Baochao Fan, Xu Song, et al.
mBio (2024) Vol. 15, Iss. 2
Open Access | Times Cited: 27
Yongxiang Zhao, Baochao Fan, Xu Song, et al.
mBio (2024) Vol. 15, Iss. 2
Open Access | Times Cited: 27
Human Tick-Borne Diseases and Advances in Anti-Tick Vaccine Approaches: A Comprehensive Review
Marie-Édith Nepveu-Traversy, Hugues Fausther‐Bovendo, George Babuadze
Vaccines (2024) Vol. 12, Iss. 2, pp. 141-141
Open Access | Times Cited: 16
Marie-Édith Nepveu-Traversy, Hugues Fausther‐Bovendo, George Babuadze
Vaccines (2024) Vol. 12, Iss. 2, pp. 141-141
Open Access | Times Cited: 16
mRNA vaccines for infectious diseases — advances, challenges and opportunities
Norbert Pardi, Florian Krammer
Nature Reviews Drug Discovery (2024)
Closed Access | Times Cited: 16
Norbert Pardi, Florian Krammer
Nature Reviews Drug Discovery (2024)
Closed Access | Times Cited: 16
Assessment of a quadrivalent nucleoside-modified mRNA vaccine that protects against group 2 influenza viruses
Meagan McMahon, George O’Dell, Jessica Tan, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 45
Open Access | Times Cited: 65
Meagan McMahon, George O’Dell, Jessica Tan, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 45
Open Access | Times Cited: 65
Vaccines for Human Schistosomiasis: Recent Progress, New Developments and Future Prospects
Adebayo J. Molehin, Donald P. McManus, Hong You
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 4, pp. 2255-2255
Open Access | Times Cited: 54
Adebayo J. Molehin, Donald P. McManus, Hong You
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 4, pp. 2255-2255
Open Access | Times Cited: 54
Immunopeptidomics-based design of mRNA vaccine formulations against Listeria monocytogenes
Rupert L. Mayer, R Verbeke, Caroline Asselman, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 52
Rupert L. Mayer, R Verbeke, Caroline Asselman, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 52
Recent Advances in Tick Antigen Discovery and Anti-Tick Vaccine Development
Muhammad Abbas, Mohamed Amine Jmel, Imen Mekki, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4969-4969
Open Access | Times Cited: 33
Muhammad Abbas, Mohamed Amine Jmel, Imen Mekki, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4969-4969
Open Access | Times Cited: 33
Dome1–JAK–STAT signaling between parasite and host integrates vector immunity and development
Vipin Singh Rana, Chrysoula Kitsou, Shraboni Dutta, et al.
Science (2023) Vol. 379, Iss. 6628
Open Access | Times Cited: 27
Vipin Singh Rana, Chrysoula Kitsou, Shraboni Dutta, et al.
Science (2023) Vol. 379, Iss. 6628
Open Access | Times Cited: 27
Malaria: influence of Anopheles mosquito saliva on Plasmodium infection
Gunjan Arora, Yu-Min Chuang, Photini Sinnis, et al.
Trends in Immunology (2023) Vol. 44, Iss. 4, pp. 256-265
Open Access | Times Cited: 26
Gunjan Arora, Yu-Min Chuang, Photini Sinnis, et al.
Trends in Immunology (2023) Vol. 44, Iss. 4, pp. 256-265
Open Access | Times Cited: 26
A tick saliva serpin, IxsS17 inhibits host innate immune system proteases and enhances host colonization by Lyme disease agent
Thu-Thuy Nguyen, Tae Heung Kim, Emily Bencosme-Cuevas, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 2, pp. e1012032-e1012032
Open Access | Times Cited: 12
Thu-Thuy Nguyen, Tae Heung Kim, Emily Bencosme-Cuevas, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 2, pp. e1012032-e1012032
Open Access | Times Cited: 12
Evolution of tick vaccinology
José de la Fuente, Srikant Ghosh
Parasitology (2024), pp. 1-8
Open Access | Times Cited: 12
José de la Fuente, Srikant Ghosh
Parasitology (2024), pp. 1-8
Open Access | Times Cited: 12
Tick Control Strategies: Critical Insights into Chemical, Biological, Physical, and Integrated Approaches for Effective Hard Tick Management
Tsireledzo Goodwill Makwarela, Nimmi Seoraj-Pillai, Tshifhiwa Nangammbi
Veterinary Sciences (2025) Vol. 12, Iss. 2, pp. 114-114
Open Access | Times Cited: 1
Tsireledzo Goodwill Makwarela, Nimmi Seoraj-Pillai, Tshifhiwa Nangammbi
Veterinary Sciences (2025) Vol. 12, Iss. 2, pp. 114-114
Open Access | Times Cited: 1
Pre-clinical strategies and emerging technologies driving advances in the alpha-gal syndrome
Loren D. Erickson, Jeffrey M. Wilson, Kayla Cramton, et al.
Allergology International (2025)
Open Access | Times Cited: 1
Loren D. Erickson, Jeffrey M. Wilson, Kayla Cramton, et al.
Allergology International (2025)
Open Access | Times Cited: 1
Fourteen anti-tick vaccine targets are variably conserved in cattle fever ticks
Joseph D. Busch, Nathan E. Stone, Grant L. Pemberton, et al.
Parasites & Vectors (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 1
Joseph D. Busch, Nathan E. Stone, Grant L. Pemberton, et al.
Parasites & Vectors (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 1
Understanding pathogen survival and transmission by arthropod vectors to prevent human disease
Carolina Barillas‐Mury, José M. C. Ribeiro, Jesús G. Valenzuela
Science (2022) Vol. 377, Iss. 6614
Closed Access | Times Cited: 37
Carolina Barillas‐Mury, José M. C. Ribeiro, Jesús G. Valenzuela
Science (2022) Vol. 377, Iss. 6614
Closed Access | Times Cited: 37
Host Immune Responses to Salivary Components - A Critical Facet of Tick-Host Interactions
Abid Ali, Ismail Zeb, Abdulaziz Alouffi, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 35
Abid Ali, Ismail Zeb, Abdulaziz Alouffi, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 35
Human type I IFN deficiency does not impair B cell response to SARS-CoV-2 mRNA vaccination
Aurélien Sokal, Paul Bastard, Pascal Chappert, et al.
The Journal of Experimental Medicine (2022) Vol. 220, Iss. 1
Open Access | Times Cited: 33
Aurélien Sokal, Paul Bastard, Pascal Chappert, et al.
The Journal of Experimental Medicine (2022) Vol. 220, Iss. 1
Open Access | Times Cited: 33
The mRNA Vaccine Technology Era and the Future Control of Parasitic Infections
Hong You, Malcolm K. Jones, Catherine A. Gordon, et al.
Clinical Microbiology Reviews (2023) Vol. 36, Iss. 1
Open Access | Times Cited: 22
Hong You, Malcolm K. Jones, Catherine A. Gordon, et al.
Clinical Microbiology Reviews (2023) Vol. 36, Iss. 1
Open Access | Times Cited: 22
Rodent-targeted approaches to reduce acarological risk of human exposure to pathogen-infected Ixodes ticks
Lars Eisen
Ticks and Tick-borne Diseases (2023) Vol. 14, Iss. 2, pp. 102119-102119
Open Access | Times Cited: 22
Lars Eisen
Ticks and Tick-borne Diseases (2023) Vol. 14, Iss. 2, pp. 102119-102119
Open Access | Times Cited: 22
DNA lipid nanoparticle vaccine targeting outer surface protein C affords protection against homologous Borrelia burgdorferi needle challenge in mice
Annabelle Pfeifle, Sathya N. Thulasi Raman, Casey Lansdell, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 18
Annabelle Pfeifle, Sathya N. Thulasi Raman, Casey Lansdell, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 18
Interventions for the control of Crimean-Congo hemorrhagic fever and tick vectors
José de la Fuente, S. Ghosh, Laetitia Lempereur, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 7
José de la Fuente, S. Ghosh, Laetitia Lempereur, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 7